Repligen [RGEN] vs Avantor [AVTR] Detailed Stock Comparison
Repligen
NASDAQ
Loading...
Avantor
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Repligen wins in 4 metrics, Avantor wins in 15 metrics, with 0 ties. Avantor appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Repligen | Avantor | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 511.11 | 14.15 | Avantor |
| Price-to-Book Ratio | 4.06 | 1.55 | Avantor |
| Debt-to-Equity Ratio | 33.28 | 67.49 | Repligen |
| PEG Ratio | 3.19 | -0.40 | Avantor |
| EV/EBITDA | 65.99 | 12.70 | Avantor |
| Profit Margin (TTM) | -2.05% | 10.31% | Avantor |
| Operating Margin (TTM) | 5.28% | 7.63% | Avantor |
| EBITDA Margin (TTM) | 5.28% | 7.63% | Avantor |
| Return on Equity | -0.68% | 11.73% | Avantor |
| Return on Assets (TTM) | 1.13% | 3.24% | Avantor |
| Free Cash Flow (TTM) | $142.49M | $692.00M | Avantor |
| 1-Year Return | 8.13% | -43.07% | Repligen |
| Price-to-Sales Ratio (TTM) | 12.42 | 1.46 | Avantor |
| Enterprise Value | $8.34B | $13.54B | Avantor |
| EV/Revenue Ratio | 12.38 | 2.03 | Avantor |
| Gross Profit Margin (TTM) | 49.98% | 32.92% | Repligen |
| Revenue per Share (TTM) | $12 | $10 | Repligen |
| Earnings per Share (Diluted) | $-0.25 | $1.01 | Avantor |
| Beta (Stock Volatility) | 1.09 | 0.98 | Avantor |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Repligen vs Avantor Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Repligen | 0.92% | 20.96% | 24.36% | 20.63% | 29.27% | 4.93% |
| Avantor | -1.40% | 19.00% | 7.31% | 4.29% | -7.49% | -33.54% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Repligen | 8.13% | -22.44% | -12.10% | 395.87% | 4,314.71% | 4,590.63% |
| Avantor | -43.07% | -28.04% | -42.40% | -2.83% | -2.83% | -2.83% |
News Based Sentiment: Repligen vs Avantor
Repligen
News based Sentiment: POSITIVE
October saw a significant surge in positive analyst coverage for Repligen, with multiple upgrades and price target increases following strong Q2 2025 financial results. This widespread optimism, coupled with a promising outlook for future growth and a strategic partnership, indicates a substantial shift in investor sentiment and positions the company for continued success.
Avantor
News based Sentiment: MIXED
October was a pivotal month for Avantor, characterized by a blend of positive developments like a new board appointment and cost reduction initiatives, alongside mixed analyst sentiment and a fluctuating stock price. The potential for a buyout adds a significant layer of complexity, making this a crucial period for investors to assess the company's direction.
Performance & Financial Health Analysis: Repligen vs Avantor
| Metric | RGEN | AVTR |
|---|---|---|
| Market Information | ||
| Market Cap | $8.37B | $9.74B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 969,310 | 10,132,900 |
| 90 Day Avg. Volume | 852,013 | 11,070,000 |
| Last Close | $150.10 | $14.09 |
| 52 Week Range | $102.97 - $182.52 | $10.82 - $26.14 |
| % from 52W High | -17.76% | -46.10% |
| All-Time High | $327.32 (Sep 20, 2021) | $44.37 (Sep 20, 2021) |
| % from All-Time High | -54.14% | -68.24% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | -0.01% |
| Quarterly Earnings Growth | 1.60% | -0.30% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | 0.10% |
| Operating Margin (TTM) | 0.05% | 0.08% |
| Return on Equity (TTM) | -0.01% | 0.12% |
| Debt to Equity (MRQ) | 33.28 | 67.49 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $36.65 | $9.22 |
| Cash per Share (MRQ) | $12.60 | $0.66 |
| Operating Cash Flow (TTM) | $132.11M | $681.80M |
| Levered Free Cash Flow (TTM) | $155.35M | $688.84M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Repligen vs Avantor
| Metric | RGEN | AVTR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 511.11 | 14.15 |
| Forward P/E | 83.56 | 12.65 |
| PEG Ratio | 3.19 | -0.40 |
| Price to Sales (TTM) | 12.42 | 1.46 |
| Price to Book (MRQ) | 4.06 | 1.55 |
| Market Capitalization | ||
| Market Capitalization | $8.37B | $9.74B |
| Enterprise Value | $8.34B | $13.54B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 12.38 | 2.03 |
| Enterprise to EBITDA | 65.99 | 12.70 |
| Risk & Other Metrics | ||
| Beta | 1.09 | 0.98 |
| Book Value per Share (MRQ) | $36.65 | $9.22 |
Financial Statements Comparison: Repligen vs Avantor
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RGEN | AVTR |
|---|---|---|
| Revenue/Sales | $182.37M | $1.58B |
| Cost of Goods Sold | $91.22M | $1.05B |
| Gross Profit | $91.14M | $534.90M |
| Research & Development | $13.96M | N/A |
| Operating Income (EBIT) | $5.96M | $147.40M |
| EBITDA | $33.81M | $230.80M |
| Pre-Tax Income | $18.22M | $85.70M |
| Income Tax | $3.35M | $21.20M |
| Net Income (Profit) | $14.87M | $64.50M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RGEN | AVTR |
|---|---|---|
| Cash & Equivalents | $697.23M | $315.70M |
| Total Current Assets | $1.03B | $2.28B |
| Total Current Liabilities | $152.00M | $2.03B |
| Long-Term Debt | $668.54M | $3.28B |
| Total Shareholders Equity | $1.99B | $6.10B |
| Retained Earnings | $413.18M | $2.27B |
| Property, Plant & Equipment | $265.24M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RGEN | AVTR |
|---|---|---|
| Operating Cash Flow | $14.16M | $86.60M |
| Capital Expenditures | $-3.52M | N/A |
| Free Cash Flow | $10.58M | $81.30M |
| Debt Repayment | N/A | $-31.30M |
| Common Stock Repurchase | N/A | $-4.90M |
Short Interest & Institutional Ownership Analysis
| Metric | RGEN | AVTR |
|---|---|---|
| Shares Short | 3.54M | 25.06M |
| Short Ratio | 5.07 | 2.26 |
| Short % of Float | 0.08% | 0.05% |
| Average Daily Volume (10 Day) | 969,310 | 10,132,900 |
| Average Daily Volume (90 Day) | 852,013 | 11,070,000 |
| Shares Outstanding | 56.09M | 680.80M |
| Float Shares | 52.66M | 663.95M |
| % Held by Insiders | 0.06% | 0.01% |
| % Held by Institutions | 0.99% | 1.06% |
Dividend Analysis & Yield Comparison: Repligen vs Avantor
| Metric | RGEN | AVTR |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |